HURA - TuHURA Biosciences Inc. P/S multiplikatori

TuHURA (HURA) kompaniyasining korporativ logotipi

TuHURA Biosciences, Inc. (HURA) uchun EV/Revenue koeffitsienti beqaror bozor kutuvlarini aks ettiradi, bunda qiymati bazaviy ko'rsatkich vazifasini o'taydi. Ushbu narx harakati o'simtaga qarshi vaksinalarni ishlab chiqishning murakkabligi va FDA ning qat'iy nazorati bilan bog'liqdir. Shu bilan birga, kompaniyaning immunoterapiya sohasidagi yetakchilik maqomi ilmiy hamjamiyat orasida ishonchni mustahkamlaydi. Joriy tendentsiya birlashuvdan keyingi boshqaruv integratsiyasining samaradorligiga va yangi klinik sinov bosqichlarining ishga tushirilishiga bog'liq.

HURA: tuhurabio.com Kapitalizatsiyaning daromadga nisbati 04.07.2022 - 16.11.2026

tuhurabio.com (HURA) kompaniyasining tahliliy kesimlari

- kotirovkalar va tahlilchilar prognozi:
Kompaniyaning jamlanma tahliliyoti:TuHURA, HURA
TuHURA Biosciences, Inc. tayyor mahsulotlari

P/S koeffitsiyenti biznesning bozor qiymatini uning daromadlariga nisbatan aks ettiradi va qarz yukini hisobga olmagan holda pul oqimini monetizatsiya qilish samaradorligini baholash imkonini beradi. TuHURA Biosciences, Inc. (HURA) uchun, ulkan R&D xarajatlari va vaksinalarning FDA tomonidan qat'iy nazoratini hisobga olgan holda, joriy P/S koeffitsiyenti bozor kapitalizatsiyasini texnologiyaning haqiqiy tijoratlashtirish sur'atlari bilan muvofiqlashtirishga yordam beradi va baholash tahlilidan hissiy moyillikni bartaraf etadi.

Raqobatdosh kompaniyalar

ONC - Sotuvga nisbatan narx|P/S multiplikatori HALO (Halozyme Therapeutics, Inc.)|Revolution Medicines (RVMD) - Sotuvga nisbatan narx|ascentage.com - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati CGON (cgoncology.com)|URGN: P/S multiplikatori|Bicara Therapeutics Inc (BCAX) - P/S multiplikatori|Narxning daromadga nisbati personalis.com|Kapitalizatsiyaning daromadga nisbati Erasca Corp (ERAS)|Kapitalizatsiyaning daromadga nisbati DCTH (Delcath)|Narx/daromad koeffitsiyenti Y-mAbs Therapeutics, Inc.|P/S multiplikatori AURA (Aura Biosciences Inc)|Bozor kapitallashuvining daromadga nisbati CADL|ARAY: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti sellaslifesciences.com SLS|ACTU (Actuate Therapeutics, Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati CTOR|TARA (Protara Therapeutics, Inc.) - P/S multiplikatori|P/S multiplikatori Fate Therapeutics Inc|P/S multiplikatori WHWK|P/S multiplikatori TScan Therapeutics Inc (TCRX)|Narxning daromadga nisbati championsoncology.com CSBR|XBIT - Kapitalizatsiyaning daromadga nisbati|CVM - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati OSTX (OS Therapies)|RADX: P/S multiplikatori|Artiva Biotherapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|ANL (Adlai Nortye) - P/S multiplikatori|P/S multiplikatori verupharma.com|Kapitalizatsiyaning daromadga nisbati TPST (tempesttx.com)|Kapitalizatsiyaning daromadga nisbati Xilio Therapeutics Inc XLO|P/S multiplikatori RENB (Enochian BioSciences)|Mural Bio - Narxning daromadga nisbati|KAPA - Narxning daromadga nisbati|OnKure Therapeutics (OKUR) - Kapitalizatsiyaning daromadga nisbati|GDTC: P/S multiplikatori|Sotuvga nisbatan narx Curis Corp (CRIS)|APLM (apollomicsinc.com) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Tharimmune Corp (THAR)|P/S multiplikatori ADVB|GNPX - Sotuvga nisbatan narx|Narxning daromadga nisbati calidibio.com CLDI|SBFM - Kapitalizatsiyaning daromadga nisbati|XBIO - Narxning daromadga nisbati|SLRX: Narxning daromadga nisbati|Purple Biotech (PPBT) - Narxning daromadga nisbati|AON - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati BGNE|P/S multiplikatori Checkpoint Therapeutics Inc.|P/S multiplikatori ELEV|Kapitalizatsiyaning daromadga nisbati iCAD ICAD|P/S multiplikatori IKNA (Ikena Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd